BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35998415)

  • 21. Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.
    Hata K; Yanagihara T; Matsubara K; Kunimura K; Suzuki K; Tsubouchi K; Eto D; Ando H; Uehara M; Ikegame S; Baba Y; Fukui Y; Okamoto I
    Front Immunol; 2023; 14():1145814. PubMed ID: 36949950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia.
    Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S
    Respiration; 2005; 72(1):39-45. PubMed ID: 15753633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK and NKT-like cells in granulomatous and fibrotic lung diseases.
    Bergantini L; Cameli P; d'Alessandro M; Vagaggini C; Refini RM; Landi C; Pieroni MG; Spalletti M; Sestini P; Bargagli E
    Clin Exp Med; 2019 Nov; 19(4):487-494. PubMed ID: 31485847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchoalveolar lavage in idiopathic interstitial lung diseases.
    Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T
    Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Utility of Bronchoalveolar Lavage Lymphocytosis in Patients with Interstitial Lung Diseases.
    Tzilas V; Digalaki A; Bouros E; Avdoula E; Tzouvelekis A; Bouros D
    Respiration; 2023; 102(11):944-947. PubMed ID: 37866357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Role of Bronchoalveolar Lavage in the Diagnosis of Idiopathic Pulmonary Fibrosis: An Investigation of the Relevance of the Protein Content].
    Schildge J; Frank J; Klar B
    Pneumologie; 2016 Jul; 70(7):435-41. PubMed ID: 27218212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis.
    Reynolds SP; Jones KP; Edwards JH; Davies BH
    Sarcoidosis; 1989 Sep; 6(2):125-34. PubMed ID: 2602684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
    Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis.
    Lee JU; Chang HS; Lee HJ; Jung CA; Bae DJ; Song HJ; Park JS; Uh ST; Kim YH; Seo KH; Park CS
    BMC Pulm Med; 2017 Feb; 17(1):39. PubMed ID: 28202030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis.
    Adderley N; Humphreys CJ; Barnes H; Ley B; Premji ZA; Johannson KA
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32265306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.
    Katoh S; Ikeda M; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Oka M
    Lung; 2015 Oct; 193(5):683-9. PubMed ID: 26249221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
    Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
    Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
    Domagała-Kulawik J
    Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia.
    Park CS; Chung SW; Ki SY; Lim GI; Uh ST; Kim YH; Choi DI; Park JS; Lee DW; Kitaichi M
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1162-8. PubMed ID: 10988147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of S100A9 and KL-6 in common interstitial lung diseases.
    Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
    Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs).
    Kopiński P; Balicka-Ślusarczyk B; Dyczek A; Szpechciński A; Przybylski G; Jarzemska A; Wandtke T; Jankowski M; Iwaniec T; Chorostowska-Wynimko J
    Folia Histochem Cytobiol; 2011; 49(4):636-45. PubMed ID: 22252758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis.
    Horimasu Y; Yamaguchi K; Sakamoto S; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Orphanet J Rare Dis; 2021 Jul; 16(1):298. PubMed ID: 34217348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.